We evaluated InCytokine by profiling wild-type microglia, TREM2 knockout, and Alzheimer's disease-associated <i>TREM2 R47H</i> variant cells in response to lipopolysaccharide and sulfatide exposure. This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.